17 Philipp D. Mayhew and Ameet Singh Laparoscopic cholecystectomy (LC) was first introduced into the armamentarium of human hepatobiliary surgeons by the German surgeon Erich Muhe in 1985. The procedure is widely credited with giving rise to the modern era of minimally invasive surgery in the human field and became widespread very quickly as general surgeons rapidly adopted the technique. In North America, the laparoscopic approach is currently used for approximately 90% of cholecystectomy procedures performed. The principal indications for the procedure in humans are for gallstone-related disease. Humans with symptomatic gallstones generally have straightforward indications for LC. Currently, there are very few indications in humans for open cholecystectomy (OC) with only suspected gallbladder neoplasia and some less common complex choledochal defects remaining as indications for an open approach.1 Intraoperative complications in LC requiring conversion remain as an occasional cause of OC in humans with large meta-analyses of LC demonstrating conversion rates around 2% to 10%2-5 One of the major contributing factors for the rapid acceptance and paradigm shift toward LC for the treatment of gallbladder disease was that significant improvements in outcomes have been documented. A large meta-analysis of 38 trials concluded that LC is associated with shorter hospital stays and diminished convalescence compared with OC for symptomatic cholelithiasis.6 There has, however, been controversy in the human literature with regard to whether complications rates associated with LC surpass those seen in OC. During the development of the procedure in the late 1980s and early 1990s, concern for a greater incidence of biliary leaks, principally arising from common duct lacerations, was suspected. However, in more recent years, studies have found that biliary leaks occur in as few as 0.4% to 0.7% of cases, and no difference in complications rates were noted in one large meta-analysis of open and laparoscopic cases.6,7 It should be remembered, however, that as with most technically challenging procedures, surgical experience and case volume have been shown to affect the outcomes of the procedure in humans with high-volume surgeons achieving superior results to those with lower volumes.8 In small animals, surgical disease of the extrahepatic biliary tract is far less common than in humans primarily because of the uncommon occurrence of gallstone-related disease and primary gallbladder neoplasia. Therefore, few case reports exist discussing LC for management of clinical feline or canine patients with gallbladder disease.9 In many small animal patients with primary disease of the gallbladder, the presence of bile peritonitis or extrahepatic biliary tract obstruction (EHBO) likely rules out the ability to perform LC at this point in time. Therefore, of the range of pathologies seen in small animal patients, uncomplicated gallbladder mucoceles (GBMs), and patients with symptomatic cholelithiasis without choledochal stones may be good indications for LC.9 In the overall population of dogs, the prognosis for successful surgical treatment of GBM is fair but associated with perioperative mortality rates of 22% to 40%.10-14 This high mortality rate is most likely attributable to the clinical consequences of EHBO and peritonitis in a proportion of cases and the fact that in many cases, these dogs are systemically highly compromised at time of hospital admission. Intra- and persistent postoperative hypotension has been reported in a large proportion of cases undergoing surgery for EHBO, further complicating perioperative outcomes.15-17 However, in approximately 20% of cases, GBMs are detected as an incidental finding without the presence of obstructive disease or peritonitis present, and these cases may form a cohort of dogs that are amenable to management with LC.11 It remains controversial whether dogs with GBMs that do not exhibit clinical signs related to the biliary system should undergo cholecystectomy, but this course of therapy does have the advantage of removing the diseased gallbladder at a time when the patient is stable and without the complications of EHBO and peritonitis that may be present at a future time. Recently, medical management of two dogs with GBM appeared to reverse the mucus buildup in the gallbladder of these dogs.17 However, it is not known at this time which dogs should be candidates for cholecystectomy and which can be treated medically with careful monitoring. Future studies are required to evaluate these potential therapeutic options for this cohort of patients. Cholelithiasis is uncommon in small animal patients and sometimes an incidental finding. There are currently no reports of management of cholelithiasis using LC, but it is thought that choleliths originate in the gallbladder, so if present and associated with significant morbidity, cholecystectomy may be indicated. However, approximately 50% of dogs with cholelithiasis in one study had choledocholiths with or without calculi in the gallbladder, so the application of LC in this cohort of patients needs to be considered in light of the possibility that choledocholiths could be missed and lead to ongoing or future EHBO.18 The gallbladder lies within the hepatic fossa that is bordered by the right medial and quadrate lobes of the liver. There is a variably well-adhered attachment of the gallbladder fundus and body to the hepatic parenchyma of these lobes. The neck of the gallbladder tapers to the beginning of the cystic duct. The cystic duct extends from the gallbladder neck to the point at which the first hepatic duct joins. It is just distal to the junction of the first hepatic duct that ligation of the cystic duct takes place during LC. The common bile duct continues toward its insertion into the duodenum at the major duodenal papilla in dogs and cats and receives tributary hepatic ducts that number two to eight in dogs.19 The blood supply to the gallbladder is through the cystic artery that is a branch of the hepatic artery. The cystic artery lies in close association with the cystic duct, and the two structures are usually ligated together during LC. Candidates for LC should receive a thorough diagnostic evaluation before undergoing the procedure. Comorbidities need to be ruled out, and a thorough evaluation of the pathology of the hepatobiliary tract needs to be obtained. A complete blood count and biochemical evaluation along with a urinalysis should be obtained. Elevations in hepatobiliary enzymes and total bilirubin are commonly found in dogs with gallbladder disease and should be noted. There may be an association between certain endocrinopathies and GBM formation in dogs with one study demonstrating that 21% of dogs with GBM were diagnosed with concurrent hyperadrenocorticism.20 Changes associated with hyperadrenocorticism, such as elevations of alkaline phosphatase and cholesterol, present on preoperative blood work in the presence of consistent clinical signs should prompt an endocrinologic evaluation for the condition. Evaluation of coagulation status is also warranted in this patient population despite the incidence of significant coagulopathy being relatively low because significant hemorrhage is possible during dissection.21 Diagnostic imaging is an equally important part of the preoperative diagnostic evaluation. Thoracic radiographs are indicated to rule out clinically significant comorbidities in the thorax. Abdominal radiographs are usually nonspecific, although most choleliths in cats and dogs are radiopaque as they are most often composed of calcium bilirubinate (most common in dogs) or calcium carbonate (most common in cats).18,19 Abdominal ultrasonography is a vital part of the preoperative diagnostic evaluation and can provide critical evaluation of gallbladder wall thickness, size, presence of choleliths, pericholecystic inflammation, and degree to which mucus is filling the lumen in cases with GBM.22 Ultrasonographic characteristics of GBM have been described and often include enlargement of the gallbladder with a typical immobile stellate or finely striated ultrasonographic appearance (“kiwi” gallbladder).10 Characteristics of the cystic and common bile ducts such as diameter (normal common bile duct diameter in cats and dogs is ∼3–4 mm), discontinuity, and presence or absence of choledocholithiasis or masses involving the area can usually be diagnosed. Changes can be monitored over time with repeated ultrasound examinations providing vital information on whether changes are progressive or static. This is important information because extrahepatic biliary tract distension can remain after an episode of EHBO, so the presence of distension does not always indicate current obstruction. Because so few LCs have been reported to date in veterinary patients, case selection has not been thoroughly evaluated and is largely based on anecdote. In dogs with GBM, it is suggested that EHBO is a contraindication for LC at this point in time because of the risk of persistent postoperative EHBO. The thick, sludgy bile that is produced in the gallbladder readily moves down into the common bile duct and hepatic ducts, and in patients with evidence of obstruction, it is recommended that a technique that allows flushing of the bile from the common duct be performed. This is despite a recent study that failed to show a significant difference in outcome in dogs undergoing cholecystectomy for GBM that had common bile duct flushing compared with those that did not.14 Common bile duct flushing has not been reported to date in conjunction with LC. In general, if the serum total bilirubin is significantly elevated or if there is ultrasonographic evidence of obstruction demonstrated by significant common bile duct or gallbladder enlargement, the authors suggest that an OC be pursued. In the future, if development of endoscopic retrograde cholangiography (ERC) or laparoscopic common bile duct exploration can be perfected in these species, the prospect of performing LC in animals without a patent common bile duct may become an option. ERC has been documented in healthy research animals but not yet in a significant population of clinical patients with EHBO.23,24 A further contraindication to LC in patients with gallbladder disease is evidence of bile peritonitis. If discontinuity of the extrahepatic biliary tract is present, thorough evaluation for leakage of bile from one or more sites should be performed, and this may be challenging to do laparoscopically. Additionally, because of the ability of bile salts to contribute to severe chemical peritonitis and the high mortality rate associated with bile peritonitis (especially when bacterial infection is present) in small animal patients, thorough lavage of the entire peritoneal cavity should be performed.9,25 Despite some reports in humans of laparoscopic treatment of bile peritonitis,26,27 it is unknown whether lavage can be performed as effectively laparoscopically as it can via a celiotomy approach. Future studies may find that less invasive peritoneal drainage techniques are adequate for management of dogs with bile peritonitis, but at present, data have not been reported in small animal patients. In dogs and cats with symptomatic or asymptomatic cholelithiasis, LC may potentially be indicated. Again, obstructive disease and the presence of bile peritonitis should be ruled out in these patients before proceeding with LC. The presence of choleliths in the common bile duct is a contraindication for LC given the need to remove the stones by retrograde flushing or choledochotomy. Necrotizing cholecystitis may be an indication for LC, although many of these canine patients present with rupture of the biliary system and bile peritonitis at presentation, so LC should be used with caution in this cohort of patients.28 In preparation for LC in dogs and cats, a wide clip of the entire abdomen from 5 cm cranial to the xiphoid process to the caudal prepuce or vulva caudally is recommended. Laterally, the patient should be clipped to the dorsal third of the abdominal wall to allow dorsally positioned ports to be placed. The entire area is aseptically scrubbed for surgery. The endoscopic tower is generally positioned at the head of the patient with the anesthesia machine and anesthesia staff located to one side (Figure 17.1
Laparoscopic Cholecystectomy
Preoperative Considerations
Surgical Anatomy
Preoperative Diagnostic Evaluation
Patient Selection
Patient Preparation
Surgical Preparation
Operating Room Setup and Patient Positioning
Stay updated, free articles. Join our Telegram channel